Scientists from K-State’s Biosecurity Research Center Institute are part of a team that has developed a promising vaccine that could be used to stop the Zika virus.
The vaccine, a DNA vaccine, is considered to be safer and more effective against the virus and could offer more long-term protection at a lower cost.
Stephen Higgs, director of the facility said that the vaccine “is a successful advancement in developing control strategies for Zika virus by creating widespread immunity in susceptible populations.”
Higgs also added that one shot of this vaccine could offer years of protection at an affordable cost, particularly for Latin American and African countries.
The next step for the vaccine will be testing its safety and effectiveness in humans.
The development of the vaccine was led by the National Institute of Health and also involved researchers with the Federal University of Rio de Janeiro, Harvard Medical School, the Frederick National Laboratory for Cancer Research, Bioqual, and the Walter Reed Army Institute of Research.
The post K-State researchers contribute to potential Zika vaccine appeared first on 1350 KMAN.
